Acta Oncologica

Aims & Scope

With its broad scope in oncology Acta Oncologica provides a forum for the exchange of information on etiology, prevention, diagnosis and treatment for all cancer types.

The journal publishes contributions relevant to experimental and clinical cancer research and welcomes articles in emerging areas such as biotechnology and diagnostic approaches, molecular epidemiology, imaging and radiotherapy, clinical trials, next-generation therapeutics in cancer, rehabilitation and survivorship perspectives.

Published article types include: •Original research •Reviews •Letters/Brief Communications •Editorial comments.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.2
2024	2.70

SJR (SCImago Journal Rank)

Year	Value
2024	0.778

Quartile

Year	Value
2024	Q2

Journal Rank

Year	Value
2024	7044

Journal Citation Indicator

Year	Value
2024	1458

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The hazard of accelerated tumor clonogen repopulation during radiotherapy

  Citation: 1310

  Authors: H. R., J. M. G., B.

• The completeness of the Swedish Cancer Register – a sample survey for year 1998

  Citation: 991

  Authors: Lotti, Kerstin, Lars, Mats

• Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

  Citation: 709

  Authors: Henric, Ingmar, Ingemar, Rut

• Occupation and cancer – follow-up of 15 million people in five Nordic countries

  Citation: 546

  Authors: Eero, Jan Ivar, Elsebeth, Holmfridur Kolbrun, Pär, Laufey, Elisabete, Kristina

• Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland

  Citation: 487

  Authors: Lyly, Eero, Maria

• Stereotactic Radiotherapy of Malignancies in the Abdomen: Methodological aspects

  Citation: 471

  Authors: Ingmar, Henric, Ingemar, Rut

• Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies

  Citation: 442

  Authors: Ian Matthew, George S., Alan Michael, Amtul Razzaq

• NORDCAN – a Nordic tool for cancer information, planning, quality control and research

  Citation: 442

  Authors: Gerda, Jacques, Niels, Freddie, Marianne L., Åsa, Jóanis E., Elínborg, Eero, Hans H.

• Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

  Citation: 407

  Authors: Alejandra, Wouter, Shahid M., Jacco A., Ben J. M., Peter C. J. M., Joost J., Rene P., Cees, Jan N. M., Peter C.

• More deaths from pancreatic cancer than breast cancer in the EU by 2017

  Citation: 357

  Authors: J., C., F.

---